Search for a command to run...
Cencora, Inc.
Medical Distribution
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
May 15, 2026 |  Rohit KhannaD | Stock | Buy |
| $1,001 - $15,000 |
| $257.21 |
| $281.12 |
| +9.3% |
| +8.9% |
May 6, 2026 |  Jared MoskowitzD | Stock | Sell | $1,001 - $15,000 | $252.16 | $275.04 | +9.1% | +8.6% |
May 6, 2026 | Jared MoskowitzD | Stock | Sell | $1,001 - $15,000 | $252.16 | $275.04 | +9.1% | +8.6% |
Apr 30, 2026 |  Michael T. McCaulR | Stock | Sell | $250,001 - $500,000 | $307.30 | $269.36 | -12.3% | -17.6% |
Apr 13, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $318.39 | $255.09 | -19.9% | -28.1% |
Mar 31, 2026 | Jared MoskowitzD | Stock | Buy | $1,001 - $15,000 | $313.42 | $307.30 | -2.0% | -12.5% |
Mar 30, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $309.22 | $310.71 | +0.5% | -12.1% |
Mar 23, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $319.87 | $307.59 | -3.8% | -12.4% |
Mar 23, 2026 | Jared MoskowitzD | Stock | Buy | $1,001 - $15,000 | $319.87 | $307.59 | -3.8% | -12.4% |
Mar 23, 2026 | Jared MoskowitzD | Stock | Buy | $1,001 - $15,000 | $319.87 | $307.59 | -3.8% | -12.4% |
Jan 29, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $350.69 | $371.28 | +5.9% | +7.0% |
Dec 15, 2025 | Michael T. McCaulR | Stock | Buy | $100,001 - $250,000 | $348.92 | $348.53 | -0.1% | -1.8% |
Dec 4, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $336.28 | $337.51 | +0.4% | +0.3% |
Oct 27, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $334.92 | $367.90 | +9.8% | +10.7% |
Aug 22, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $291.62 | $289.05 | -0.9% | -4.0% |
Aug 7, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $276.31 | $290.85 | +5.3% | +2.9% |
Jun 27, 2025 | Michael T. McCaulR | Stock | Sell | $50,001 - $100,000 | $297.18 | $288.18 | -3.0% | -6.6% |
May 12, 2025 |  Jefferson ShreveR | Stock | Sell | $50,001 - $100,000 | $276.40 | $285.15 | +3.2% | +0.0% |
Mar 27, 2025 |  Greg LandsmanD | Stock | Sell | $15,001 - $50,000 | $272.02 | $283.86 | +4.4% | +7.3% |
Feb 25, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $248.75 | $272.02 | +9.4% | +13.6% |
Feb 19, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $243.67 | $265.53 | +9.0% | +16.7% |
Jan 22, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $245.07 | $240.12 | -2.0% | -0.9% |
Jan 17, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $240.20 | $241.31 | +0.5% | -1.6% |
Dec 18, 2024 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $225.25 | $240.20 | +6.6% | +4.4% |
Dec 13, 2024 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $230.46 | $234.38 | +1.7% | +5.3% |
Dec 13, 2024 | Michael T. McCaulR | Stock | Sell | $50,001 - $100,000 | $230.46 | $234.38 | +1.7% | +5.3% |
Cencora Announces Updated Fiscal Year 2026 Financial Outlook
Cencora Raises FY26 Adjusted EPS Range From $17.65 - $17.90 To $17.70 - $17.90; Announces $2B Buyback Plan
Cencora (COR) Emerges as a Healthcare Leader with Robust Fundamentals and Strategic Re-Rating
Cencora Legal Probes Test Investor Confidence After Weaker Q2 Revenue Outlook
The Top 5 Analyst Questions From Cencora’s Q1 Earnings Call